Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Barberis, C., Mouillac, B. & Durroux, T. J. Endocrinol. 156, 223–229 (1998).
Donaldson, Z. R. & Young, L. J. Science 322, 900–904 (2008).
Makita, N., Manaka, K., Sato, J. & Iiri, T. Vitam. Horm. 113, 79–99 (2020).
Carpenter, B., Nehme, R., Warne, T., Leslie, A. G. & Tate, C. G. Nature 538, 104–107 (2016).
Ballesteros, J. A. & Weinstein, H. Methods Neurosci. 25, 366–428 (1995).
Tahara, A. et al. Br. J. Pharmacol. 125, 1463–1470 (1998).
Conner, M. et al. J. Biol. Chem. 282, 17405–17412 (2007).
Waltenspuhl, Y., Schoppe, J., Ehrenmann, J., Kummer, L. & Pluckthun, A. Sci. Adv. 6, eabb5419 (2020).
Zhou, Q. et al. Elife 8, e50279 (2019).
Wisniewski, K. et al. J. Med. Chem. 54, 4388–4398 (2011).
Rasmussen, S. G. et al. Nature 477, 549–555 (2011).
Erdélyi, L. et al. Endocrine Abstracts 49, https://doi.org/10.1530/endoabs.49.EP804 (2017).
Wenkert, D. et al. Mol. Cell Endocrinol. 124, 43–50 (1996).
Chini, B. et al. FEBS Lett. 397, 201–206 (1996).
Acknowledgements
We thank all staff members of the Cryo-EM Centre, Southern University of Science and Technology for their assistance in data collection. This work was partially supported by the Ministry of Science and Technology (China) grant (2018YFA0507002 to H.E.X.); National Natural Science Foundation of China (31770796 to Y.J., 81872915 to M,-W.W., 31600606 to X.Z., and 81773792 to D.Y.); National Science & Technology Major Project “Key New Drug Creation and Manufacturing Program” (2018ZX09711002-002-002 to Y.J., 2018ZX09735-001 to M.-W.W., and 2018ZX09711002-002-005 to D.Y.); Shanghai Municipal Science and Technology Major Project (2019SHZDZX02 to H.E.X.); CAS Strategic Priority Research Program (XDB37030103 to H.E.X.); Start-up funding by Fudan University (Q.Z.); Wellcome Trust 209407/Z/17/Z; National Key R&D Program of China (2016YFA0501100 to X.Z.); Guangdong Provincial Key Laboratory of Brain Connectome and Behavior (2017B030301017 to X.Z.); CAS Key Laboratory of Brain Connectome and Manipulation (2019DP173024 to X.Z.).
Author information
Authors and Affiliations
Contributions
F.Z. prepared samples for cryo-EM grid preparation; F.Z. and X.M. performed cryo-EM data collection and processing; F.Z., T.C., X.M., and X.Z. built and refined the structure model; C.Y. and D.Y. conducted functional studies and data analysis; Q.Z. and X.H. carried out docking analysis; W.Y. engineered the mini-Gs protein; F.Z. and Y.J. prepared the bulk of figures, performed the structural analysis, and drafted the manuscript; Y.J., H.E.X., and M.-W.W. supervised the studies, analyzed the data, and wrote the manuscript with inputs from all co-authors; P.W. supervised the EM studies.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Zhou, F., Ye, C., Ma, X. et al. Molecular basis of ligand recognition and activation of human V2 vasopressin receptor. Cell Res 31, 929–931 (2021). https://doi.org/10.1038/s41422-021-00480-2
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41422-021-00480-2
This article is cited by
-
Inactive structures of the vasopressin V2 receptor reveal distinct binding modes for Tolvaptan and Mambaquaretin toxin
Nature Communications (2025)
-
Structural basis of tolvaptan binding to the vasopressin V2 receptor
Acta Pharmacologica Sinica (2024)
-
Ligand recognition mechanism of the human relaxin family peptide receptor 4 (RXFP4)
Nature Communications (2023)
-
Structural insights into ligand recognition and subtype selectivity of the human melanocortin-3 and melanocortin-5 receptors
Cell Discovery (2023)
-
Structures of the endogenous peptide- and selective non-peptide agonist-bound SSTR2 signaling complexes
Cell Research (2022)